Kann Cannabis Krebs heilen?

Nein — kein klinischer Beweis dafür existiert. Cannabinoide zeigen in Zellkulturen und Tiermodellen Antitumoreffekte, aber diese Konzentrationen werden im menschlichen Körper durch orale oder inhalative Nutzung nicht erreicht. Rick Simpson Oil und ähnliche Angebote haben keine klinische Evidenz. Cannabis ist kein Kurativum und kein Ersatz für onkologische Standardtherapie.

Wofür ist Cannabis bei Krebs wirklich geeignet?

Palliativmedizinisch: Tumorschmerz (Opioid-Sparing-Effekt), Chemotherapie-Übelkeit (Nabilon/Dronabinol zugelassen), Appetitlosigkeit und Kachexie (THC stimuliert Hypothalamus-CB1), Angst, Depression und Schlafstörungen. Das ist der Bereich mit echter klinischer Evidenz und GKV-Erstattbarkeit.

Darf ich Cannabis neben meiner Chemotherapie nehmen?

Nur nach Absprache mit dem Onkologen. CBD hemmt CYP3A4 und CYP2C9 — diese Enzyme bauen viele Chemotherapeutika ab. Erhöhte Plasma-Spiegel der Krebsmittel durch Cannabis können gefährlich werden. Onkologen müssen Cannabis-Konsum kennen, um Dosierungen anpassen zu können.

Übernimmt die Krankenkasse Cannabis bei Krebs?

Ja — onkologische Erkrankungen haben eine der höchsten GKV-Genehmigungsquoten für medizinisches Cannabis. Indikationen mit bester Erfolgsquote: CINV, Tumorschmerz, Kachexie. Seit KCanG vereinfachter Prozess. Onkologe oder Hausarzt stellt Antrag — am besten alle palliativen Indikationen gleichzeitig angeben.

Cannabis and Cancer: Antitumor, Palliative and Evidence Base

Cannabis and cancer — few topics are more emotionally charged and surrounded by more misinformation. On one side, there are healing promises without evidence, on the other side, conservative medicine overlooks real palliative uses. This article clearly distinguishes between preclinical anti-tumor findings, what of that is clinically relevant, and the proven palliative medical benefits.

Overview hide

Anti-tumor effects: What the research shows

Rick Simpson Oil and the problem of healing promises

Palliative Medicine Benefits: Where Cannabis Really Helps in Cancer

Interactions with Chemotherapeutics

GKV reimbursement for cancer patients

Frequently asked questions about cannabis and cancer

Anti-tumor effects: What the research shows

Cannabinoids have shown anti-tumor effects in cell culture and animal models — with important limitations:

CB1/CB2 activation in tumor cells: THC and CBD can induce apoptosis (programmed cell death), inhibit cell proliferation, and reduce angiogenesis (new blood vessel formation in tumors) in cancer cell lines. Proven in vitro for glioblastoma, breast, prostate, and lung cancer cell lines.
Glioblastoma — the most studied tumor: Guzmán 2006 (Nature Reviews Cancer) showed in a pilot human trial with 9 glioblastoma patients (as a last resort attempt): intracranial THC injection reduced tumor cell proliferation. No control arm, no survival as an endpoint
CBD and tumor suppression: CBD showed inhibition of metastasis in animal models (breast cancer, colon cancer). Mechanism: inhibition of VEGF expression and modulation of the PI3K/Akt signaling pathway
The critical problem: In vitro effects occur at concentrations that cannot be reached in human tumor tissue. Oral/inhalative cannabis use leads to systemic levels that are orders of magnitude below the in vitro effective concentrations
Biphasic effects: Low cannabinoid concentrations can even stimulate tumor cell growth (CB1 activation at low dose levels). This finding from animal models is not yet fully understood clinically

Rick Simpson Oil and the problem of healing promises

Rick Simpson Oil (RSO, Phoenix Tears) is a highly concentrated cannabis extract marketed as a cancer cure:

Origin story: Rick Simpson claimed that he cured his skin cancer using self-made highly concentrated cannabis oil. The story spread virally — without any clinical documentation or control
Evidence for RSO: No controlled studies. No published case series with verification. No peer-reviewed data. Anecdotes that cannot be generalized
Risks of the healing promise: Patients shift or refuse proven therapies (chemotherapy, radiation, surgery) in favor of cannabis. This is medically dangerous and has led to avoidable deaths in documented cases
Clear message: Cannabis is not a curative for cancer. It is not a substitute for standard oncological treatment. The anti-tumor data are preclinical and not clinically valid. This does not change its palliative medical benefits

Palliative Medicine Benefits: Where Cannabis Really Helps in Cancer

Here the evidence is clearly stronger and clinically relevant:

Pain: Chronic tumor pain — neuropathic, nociceptive, combined — responds to cannabinoids. CB1-mediated pain modulation complements opioid therapy. Opioid reduction through cannabinoids shown in several studies (opioid-sparing effect)
CINV (Chemotherapy-induced nausea and vomiting): Nabilone and Dronabinol are approved for refractory CINV. Second-line after failure of 5-HT3+NK1+Dexamethason. Well documented — see Cannabis for Nausea and Chemotherapy
Appetite and Cachexia: Tumor cachexia is life-threatening. THC stimulates appetite via CB1 in the hypothalamus. Dronabinol has FDA approval for AIDS cachexia — used off-label for cancer-related cachexia. Weight stabilization as a goal
Anxiety and Depression: Cancer diagnosis and treatment are major psychological stressors. CBD’s effect on the amygdala and serotonin system can reduce anxiety. Sleep improvement through THC is relevant for exhausted cancer patients
Neuropathic Pain from Chemotherapy: CIPN (Chemotherapy-Induced Peripheral Neuropathy) is often treatment-resistant. Cannabinoids via TRPV1 and CB1 peripherally can modulate CIPN pain

Interactions with Chemotherapeutics

Cannabis in cancer patients requires special caution regarding interactions:

CYP Interactions: CBD inhibits CYP3A4 and CYP2C9 — two of the most important enzymes for chemotherapy metabolism. Taxanes (Paclitaxel), alkylating agents (Cyclophosphamide), tyrosine kinase inhibitors can be affected. Plasma levels can rise → increased toxicity possible
THC and CYP1A2: THC can influence CYP1A2 — relevant for Imatinib and other cancer drugs
Immunotherapy: In animal studies with checkpoint inhibitors (PD-1/PD-L1) such as Pembrolizumab, there are indications of CB2-mediated immunomodulation. Clinical relevance unclear — consult your oncologist
Duty to disclose: Cancer patients must inform their oncologist about cannabis use — not for moral reasons, but to ensure safe dosing of chemotherapy drugs

GKV reimbursement for cancer patients

Cancer = recognized indication: Oncological diseases are one of the most frequently approved indications for medical cannabis in Germany. GKV reimbursement rate for cancer patients is comparatively high
Indications with highest success rate: CINV (nausea), cancer-related pain, loss of appetite/cachexia, therapy-related sleep disturbances
Prescription: Oncologist or general practitioner with oncological care. Increasingly also specialized cannabis clinics with oncological expertise
Pragmatic approach: Cannabis as part of the palliative care concept — pain therapy, antiemetic, appetite stimulation — apply simultaneously, not one after the other

Cannabis as an antiemetic during chemotherapy — Nabilone and Dronabinol in detail: Cannabis for nausea and chemotherapy. How cannabinoids modulate pain: Cannabis and chronic pain. Interactions with medications via CYP enzymes: Cannabis interactions.

Cannabis in metabolic diseases — insulin resistance, THCV and diabetes: Cannabis and diabetes.